Backed by strong fiscal 2026 Q3 financial results, Phreesia is narrowing its revenue guidance range for the year.
The software-as-a-service and payment platform provider for the healthcare industry now sees FY26 revenues (ending Jan. 31, 2026) of $479M-$481M. Consensus is $485.88M.
Phreesia also released FY27 revenue guidance (year ends Jan. 31, 2027) of $545M-$559M. Consensus is 569.51M.
The company added it expects 6.5% of its FY27 revenue to come from its AccessOne acquisition.
Welcome to AI Investor Picks, your trusted source for investment insights, financial strategies, and business opportunities. We are dedicated to providing cutting-edge information and analysis on a wide range of investment topics, including stocks, cryptocurrency, real estate, finance, and much more.
